Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Hilmi

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Journal for Immunotherapy of Cancer|December 1, 2019
Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: current knowledge and future research directionsMarc Hilmi, Cindy Neuzillet, Julien Calderaro, et al.
Annals of Hematology|November 25, 2017
Favorable evolution of lung interstitial disease in a patient with chronic myelomonocytic leukemia treated with azacitidineMarc Hilmi, Cécile Bally, Robert Burns, et al.
JCO Global Oncology|November 5, 2020
Professional and Psychological Impacts of the COVID-19 Pandemic on Oncology Residents: A National SurveyMarc Hilmi, Alice Boilève, Anabelle Ducousso, et al.
Clinics and Research in Hepatology and Gastroenterology|February 19, 2021
Microbiome and pancreatic ductal adenocarcinomaAnnemilaï Tijeras-Raballand, Marc Hilmi, Lucile Astorgues-Xerri, et al.
Cancer Medicine|September 26, 2022
Inclusion of patients with chronic kidney disease in randomized phase 3 clinical trials in patients with prostate, breast, lung, and colorectal cancerMatthieu Delaye, Adrien Rousseau, Mélanie Try, et al.
Bulletin Du Cancer|January 15, 2019
[Going beyond microsatellite instability for immunotherapy in metastatic colorectal cancer: Consensus molecular subtypes and tumor mutational burden]Romain Cohen, Maximilien Heran, Thomas Pudlarz, et al.
Pharmacology & Therapeutics|December 7, 2018
Body composition and sarcopenia: The next-generation of personalized oncology and pharmacology?Marc Hilmi, Anne Jouinot, Robert Burns, et al.
The Lancet. Gastroenterology & Hepatology|October 22, 2023
The immunological landscape in pancreatic ductal adenocarcinoma and overcoming resistance to immunotherapyMarc Hilmi, Matthieu Delaye, Milena Muzzolini, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|November 27, 2021
Twitter as a Medical Media Among French Young Oncologists: Results from a National SurveyMatthieu Roulleaux Dugage, Natacha Naoun, Côme Bommier, et al.
Bulletin Du Cancer|April 17, 2019
[A GERCOR-AERIO national survey of oncology residents in France: Current setting and expectations regarding post-internship and research]Marc Hilmi, Benoît Rousseau, Romain Cohen, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Journal for Immunotherapy of Cancer|December 1, 2019
Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: current knowledge and future research directionsMarc Hilmi, Cindy Neuzillet, Julien Calderaro, et al.
Annals of Hematology|November 25, 2017
Favorable evolution of lung interstitial disease in a patient with chronic myelomonocytic leukemia treated with azacitidineMarc Hilmi, Cécile Bally, Robert Burns, et al.
JCO Global Oncology|November 5, 2020
Professional and Psychological Impacts of the COVID-19 Pandemic on Oncology Residents: A National SurveyMarc Hilmi, Alice Boilève, Anabelle Ducousso, et al.
Clinics and Research in Hepatology and Gastroenterology|February 19, 2021
Microbiome and pancreatic ductal adenocarcinomaAnnemilaï Tijeras-Raballand, Marc Hilmi, Lucile Astorgues-Xerri, et al.
Cancer Medicine|September 26, 2022
Inclusion of patients with chronic kidney disease in randomized phase 3 clinical trials in patients with prostate, breast, lung, and colorectal cancerMatthieu Delaye, Adrien Rousseau, Mélanie Try, et al.
Bulletin Du Cancer|January 15, 2019
[Going beyond microsatellite instability for immunotherapy in metastatic colorectal cancer: Consensus molecular subtypes and tumor mutational burden]Romain Cohen, Maximilien Heran, Thomas Pudlarz, et al.
Pharmacology & Therapeutics|December 7, 2018
Body composition and sarcopenia: The next-generation of personalized oncology and pharmacology?Marc Hilmi, Anne Jouinot, Robert Burns, et al.
The Lancet. Gastroenterology & Hepatology|October 22, 2023
The immunological landscape in pancreatic ductal adenocarcinoma and overcoming resistance to immunotherapyMarc Hilmi, Matthieu Delaye, Milena Muzzolini, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|November 27, 2021
Twitter as a Medical Media Among French Young Oncologists: Results from a National SurveyMatthieu Roulleaux Dugage, Natacha Naoun, Côme Bommier, et al.
Bulletin Du Cancer|April 17, 2019
[A GERCOR-AERIO national survey of oncology residents in France: Current setting and expectations regarding post-internship and research]Marc Hilmi, Benoît Rousseau, Romain Cohen, et al.
Pageof 5